Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Jan 2020 17:00

RNS Number : 4897B
Byotrol PLC
30 January 2020
 

 

 

Byotrol plc

("Byotrol", the "Company" or the "Group")

 

Director/PDMR Shareholding

 

 

Byotrol Plc (AIM:BYOT), the anti-microbial technology company, announces that on 30 January 2020, John Langlands, Non-Executive Chairman of the Company, and Nic Hellyer, Chief Financial Officer of the Company, purchased 1,000,000 and 500,000 ordinary shares of 0.25p each ("Ordinary Shares") respectively at prices between 1.79 and 1.83 pence per Ordinary Share, respectively (the "Purchases").

Following the Purchases, Mr. Langlands has an interest in 9,000,000 Ordinary Shares representing approximately 2.04 per cent. of the total voting rights of the Company and Nic Hellyer has an interest in 500,000 Ordinary Shares representing approximately 0.11 per cent. of the total voting rights of the Company.

 

 

 

Enquiries:

David Traynor - Chief Executive, Byotrol plc 01925 742 000

David Paton - Investor Relations 07714 190 474

finnCap Ltd 020 7110 0500(NominateAdviser & Broker)

Geoff Nash/Teddy Whiley Corporate Finance

Richard Chambers - Corporate Broking

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Noteto Editors: 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies delivers powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

 

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Langlands

2.

Reason for the Notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume - 250,000

Price - 1.7975 pence

Volume - 500,000

Price - 1.83 pence

Volume - 250,000

Price - 1.79 pence

d)

Aggregated information:

Volume - 1,000,000

Aggregated price - 1.81 pence

e)

Date of the transaction

30 January 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nic Hellyer

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume - 278,164

Price - 1.7975 pence

Volume - 221,836

Price - 1.799 pence

d)

Aggregated information:

Volume - 500,000

Aggregated Price - 1.798 pence

e)

Date of the transaction

30 January 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDZGFMVGRGGZM
Date   Source Headline
20th Aug 20151:00 pmRNSPlacing and Subscription to raise £1.4 million
14th Aug 20157:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20157:00 amRNSAgreement with Solvay
1st Jul 20158:25 amRNSHolding(s) in Company
15th Jun 20157:00 amRNSPreliminary Results
16th Apr 20157:00 amRNSTrading update
25th Nov 20147:01 amRNSInterim Results
25th Nov 20147:00 amRNSBoard Appointment
10th Nov 201410:58 amRNSNotice of Interim Results
17th Sep 20141:08 pmRNSHolding(s) in Company
29th Jul 20143:35 pmRNSResult of AGM and Completion of Placing
24th Jul 20147:00 amRNSGrant of Options
7th Jul 20147:00 amRNSANNUAL REPORT AND AGM NOTICE
25th Jun 20147:00 amRNSUnaudited Preliminary Results
25th Jun 20147:00 amRNSConditional Fundraising of £1.25m
18th Mar 20147:00 amRNSTrading Update and Directorate Changes
20th Dec 20137:00 amRNSFundraising
19th Nov 20137:00 amRNSInterim Results
31st Oct 20137:00 amRNSTotal Voting Rights
17th Oct 20133:04 pmRNSHolding(s) in Company
10th Oct 20133:11 pmRNSHolding(s) in Company
9th Oct 20137:00 amRNSDirectorate Change
3rd Oct 20137:00 amRNSAcquisition
15th Aug 20138:34 amRNSDirector/PDMR Shareholding
13th Aug 20133:12 pmRNSDirector/PDMR Shareholding
9th Aug 20132:47 pmRNSDirector/PDMR Shareholding
9th Aug 20138:20 amRNSHolding(s) in Company
25th Jul 20133:54 pmRNSResult of AGM
1st Jul 20139:28 amRNSDirector/PDMR Shareholding
25th Jun 20137:01 amRNSIssue of Equity
25th Jun 20137:00 amRNSFinal Results
19th Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSJDA with Albaad Ltd for UK & Europe
8th Feb 20137:00 amRNSCommercial & Trading Update
20th Nov 20127:00 amRNSInterim Results
1st Oct 20129:44 amRNSDirector/PDMR Shareholding
16th Aug 201210:25 amRNSDirector/PDMR Shareholding
14th Aug 20126:08 pmRNSHolding(s) in Company
13th Aug 20127:00 amRNSLicensing Agreement with Kimberly-Clark
25th Jul 20127:00 amRNSHolding(s) in Company
23rd Jul 20128:03 amRNSHolding(s) in Company
19th Jul 20123:33 pmRNSResult of AGM
19th Jul 20127:00 amRNSAGM Statement
17th Jul 201211:10 amRNSDirector/PDMR Shareholding
6th Jul 20127:00 amRNSGrant of Options
27th Jun 20127:00 amRNSDirectorate Change + Annual Report + AGM notice
19th Jun 20127:00 amRNSPreliminary Results
12th Apr 20127:00 amRNSTrading Update
10th Feb 201210:54 amRNSHolding(s) in Company
31st Jan 20122:00 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.